CoChat

Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study

Chan, Juliana C. N., Paldánius, Päivi M., Mathieu, Chantal, Stumvoll, Michael, Matthews, David R., Del Prato, Stefano · 2021 · Diabetes, Obesity and Metabolism
Cited by 24

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

We analysed glycaemic durability (sustained glycaemic control) with early combination therapy (metformin plus vildagliptin) versus metformin monotherapy, among patients with type 2 diabetes diagnosed before (young‐onset [YOD]) and after (late‐onset [LOD]) the age of 40 years, enrolled in the VERIFY trial. The primary endpoint was time to initial treatment failure (TF), defined as HbA1c of 7.0% or higher at two consecutive scheduled visits after randomization. The time to secondary TF was assessed when both groups were receiving and failing on the combination. A total of 186 (9.3%) patients had YOD and 1815 (90.7%) had LOD with a mean age difference of 20.4 years. Compared with metformin monotherapy, early combination reduced the risk of time to initial TF for both YOD (48%, P < .0006) and LOD (46%, P < .0001). With early combination, risk for time to secondary TF was reduced by 48% ( P < .0035) in YOD and 24% ( P < .0009) in LOD. Both treatment approaches were well tolerated with no unexpected safety concerns. In treatment‐naïve patients with YOD (HbA1c 6.5%‐7.5%), an early combination strategy improved attainment of the glycaemic target with durability and delayed treatment escalation compared with initial metformin monotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.14192

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 11

  1. 10.1016/j.diabres.2017.03.024 · DOI · Paper page
  2. 10.1016/j.amjmed.2014.03.018 · DOI · Paper page
  3. 10.1007/s00125-019-05074-7 · DOI
  4. 10.1186/s12933-019-0916-z · DOI · Paper page
  5. 10.1111/dom.13800 · DOI
  6. 10.1016/j.diabres.2015.11.003 · DOI
  7. 10.2337/dc19-1380 · DOI · Paper page
  8. 10.7326/M18-1900 · DOI · Paper page
  9. 10.2337/dc11-s223 · DOI · Paper page
  10. 10.1056/NEJMoa0806470 · DOI · Paper page
  11. 10.1007/s00125-012-2827-3 · DOI · Paper page

Cited by

See all 24

Metadata

Authors
Chan, J. C. N., Paldánius, P. M., Mathieu, C., Stumvoll, M., Matthews, D. R., & Del Prato, S.
Affiliations
  • Department of Medicine &amp; Therapeutics Hong Kong Institute of Diabetes and Obesity and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong China
  • Children's Hospital Helsinki University and Helsinki University Hospital Helsinki Finland
  • Department of Endocrinology UZ Gasthuisberg KU Leuven Belgium
  • Division of Endocrinology and Diabetes University Hospital Leipzig Leipzig Germany
  • Oxford Centre for Diabetes, Endocrinology and Metabolism Oxford UK
  • Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes University of Pisa Pisa Italy
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2020-09-29
Volume
23
Issue
1
Pages
245-251
ISSN
  • 1462-8902
  • 1463-1326
Cited by
24
References
10
Language
en
Funders
Novartis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.